Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Study of Efficacy and Safety of Omalizumab in Refractory Chronic Spontaneous Urticaria Patients
- Status
- COMPLETED
- Phase
- PHASE3
Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- N/A
FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Everolimus trIal for Advanced prememopausaL Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Reproductive Capacity and Iron Burden in Thalassemia
- Status
- COMPLETED
- Phase
- NA
Long-term Follow-up of Fingolimod Phase II Study Patients
- Status
- COMPLETED
- Phase
- PHASE4
Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression
- Status
- COMPLETED
- Phase
- PHASE2
Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab
- Status
- COMPLETED
- Phase
- PHASE3
Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)
- Status
- COMPLETED
- Phase
- PHASE1